Travere Therapeutics, Inc. (TVTX)

Latest Insider Confidence Score

2026Q1

51.9
Bullish

Company insider confidence (by quarter)

2013Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Broadfin Healthcare Master Fund Ltd — 2,658,854 Jan 30, 2015
Broadfin Capital, LLC — 2,658,854 Jan 30, 2015
Kotler Kevin — 2,658,854 Jan 30, 2015
Opaleye GP LLC — 2,097,671 Jan 3, 2014
Panoff Marc L — 221,100 Feb 28, 2014

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 20, 2026 Feb 24, 2026 Dube Eric M CEO Sell 23.8 -60,000 -12.17% ✓ $1.8M
Feb 17, 2026 Feb 19, 2026 REED ELIZABETH E Chief Legal Officer and GC Sell 28.8 -10,000 -8.68% ✓ $278.3K
Feb 4, 2026 Feb 5, 2026 Inrig Jula CHIEF MEDICAL OFFICER Sell 46.3 -1,779 -1.66% ✓ $57.3K
Feb 4, 2026 Feb 5, 2026 Cline Christopher R. CFO Sell 46.3 -1,745 -1.54% ✓ $56.2K
Feb 4, 2026 Feb 5, 2026 REED ELIZABETH E Chief Legal Officer and GC Sell 42.5 -2,994 -2.77% ✓ $96.4K
Jan 31, 2026 Feb 3, 2026 Dube Eric M CEO Sell 92.5 +13,713 3.27% ✓ $3.2M
Jan 31, 2026 Feb 3, 2026 Inrig Jula CHIEF MEDICAL OFFICER Sell 95.0 +21,174 24.53% ✗ $223.4K
Jan 31, 2026 Feb 3, 2026 Cline Christopher R. CFO Sell 95.0 +20,888 22.68% ✗ $232.6K
Jan 31, 2026 Feb 3, 2026 Heerma Peter CHIEF COMMERCIAL OFFICER Sell 95.0 +18,810 16.64% ✗ $234.8K
Jan 31, 2026 Feb 3, 2026 ROTE WILLIAM E. Chief Research Officer Sell 92.5 +7,644 7.54% ✓ $409.1K
Jan 31, 2026 Feb 3, 2026 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sell 95.0 +10,847 28.37% ✗ $139.2K
Jan 31, 2026 Feb 3, 2026 REED ELIZABETH E Chief Legal Officer and GC Sell 95.0 +17,935 19.87% ✗ $230.5K
Jan 23, 2026 Jan 27, 2026 Dube Eric M CEO Sell 31.3 -60,000 -6.68% ✓ $1.8M
Jan 20, 2026 Jan 21, 2026 REED ELIZABETH E Chief Legal Officer and GC Sell 28.8 -10,000 -9.97% ✓ $273.4K
Jan 5, 2026 Jan 7, 2026 Inrig Jula CHIEF MEDICAL OFFICER Sell 42.5 -2,476 -2.79% ✓ $98.4K
Dec 24, 2025 Dec 29, 2025 Heerma Peter CHIEF COMMERCIAL OFFICER Sell 38.8 -4,980 -4.22% ✓ $199.2K
Dec 24, 2025 Dec 29, 2025 ROTE WILLIAM E. Chief Research Officer Sell 8.8 -60,000 -37.16% ✓ $2.4M
Dec 24, 2025 Dec 29, 2025 Inrig Jula CHIEF MEDICAL OFFICER Sell 25.0 -15,000 -14.45% ✓ $630K
Dec 24, 2025 Dec 29, 2025 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sell 20.0 -7,402 -16.22% ✓ $296.1K
Dec 15, 2025 Dec 16, 2025 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sell 32.5 -2,910 -5.99% ✓ $104.8K
Dec 1, 2025 Dec 3, 2025 Cline Christopher R. CFO Sell 17.5 -20,000 -17.84% ✓ $700.2K
Nov 4, 2025 Nov 6, 2025 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sell 5.0 -67,115 -58.03% ✓ $2.4M
Oct 31, 2025 Nov 4, 2025 Coughlin Timothy Director Sell 12.5 -18,000 -24.49% ✓ $630.6K
Oct 31, 2025 Nov 4, 2025 Heerma Peter CHIEF COMMERCIAL OFFICER Sell 32.5 -6,669 -5.35% ✓ $195.7K
Oct 28, 2025 Oct 30, 2025 Dube Eric M CEO Sell 20.0 -120,000 -12.52% ✓ $3.6M
Oct 28, 2025 Oct 30, 2025 Heerma Peter CHIEF COMMERCIAL OFFICER Sell 41.3 -2,662 -2.09% ✓ $79.9K
Sep 23, 2025 Sep 24, 2025 Heerma Peter CHIEF COMMERCIAL OFFICER Neutral 52.5 -891 -0.69% ✓ -
Sep 22, 2025 Sep 24, 2025 REED ELIZABETH E Chief Legal Officer and GC Sell 22.5 -10,000 -10.01% ✓ $250K
Sep 3, 2025 Sep 5, 2025 Cline Christopher R. CFO Sell 51.3 -573 -0.62% ✓ $10.6K
Aug 27, 2025 Aug 28, 2025 Cline Christopher R. CFO Sell 52.5 -470 -0.50% ✓ $8.1K
Jul 1, 2025 Jul 2, 2025 Inrig Jula CHIEF MEDICAL OFFICER Sell 51.3 -815 -0.91% ✓ $11.9K
May 15, 2025 May 16, 2025 Williams Brinkley Ruth Director Neutral 90.0 +6,500 33.77% ✗ -
May 15, 2025 May 16, 2025 Squarer Ron Director Neutral 90.0 +6,500 22.51% ✗ -
May 15, 2025 May 16, 2025 Poole Sandra Director Neutral 90.0 +6,500 27.66% ✗ -
May 15, 2025 May 16, 2025 Orwin John A Director Neutral 90.0 +6,500 22.51% ✗ -
May 15, 2025 May 16, 2025 Meckler Jeffrey A Director Neutral 85.0 +6,500 8.02% ✗ -
May 15, 2025 May 16, 2025 LYONS GARY A Director Neutral 90.0 +6,500 12.75% ✗ -
May 15, 2025 May 16, 2025 COUGHLIN TIMOTHY Director Neutral 90.0 +6,500 13.27% ✗ -
May 15, 2025 May 16, 2025 Bruhn Suzanne Louise Director Neutral 90.0 +6,500 29.21% ✗ -
May 15, 2025 May 16, 2025 Baynes Roy D. Director Neutral 90.0 +6,500 20.97% ✗ -
May 2, 2025 May 5, 2025 Cline Christopher R. CFO Sell 46.3 -1,784 -1.88% ✗ $37.6K
May 2, 2025 May 5, 2025 Dube Eric M CEO Sell 35.0 -18,924 -4.32% ✓ $398.4K
May 2, 2025 May 5, 2025 Heerma Peter CHIEF COMMERCIAL OFFICER Sell 46.3 -1,771 -1.36% ✗ $37.3K
May 2, 2025 May 5, 2025 ROTE WILLIAM E. Chief Research Officer Sell 37.5 -3,198 -3.09% ✓ $67.3K
May 2, 2025 May 5, 2025 REED ELIZABETH E Chief Legal Officer and GC Sell 32.5 -4,920 -5.21% ✓ $103.6K
Apr 11, 2025 Apr 14, 2025 Cline Christopher R. CFO Sell 52.5 -48 -0.05% ✗ $630.9
Feb 10, 2025 Feb 12, 2025 ROTE WILLIAM E. President Sell 32.5 -5,200 -5.01% ✓ $122.4K
Feb 10, 2025 Feb 12, 2025 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Sell 28.8 -8,000 -8.21% ✓ $188.2K
Feb 11, 2025 Feb 12, 2025 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sell 20.0 -54,244 -14.93% ✓ $1.4M
Feb 10, 2025 Feb 12, 2025 Heerma Peter CHIEF COMMERCIAL OFFICER Sell 37.5 -5,642 -4.32% ✓ $137.3K
Feb 11, 2025 Feb 12, 2025 Dube Eric M CEO Sell 38.8 -11,375 -2.64% ✓ $273.5K
Feb 10, 2025 Feb 12, 2025 Inrig Jula CHIEF MEDICAL OFFICER Sell 42.5 -2,568 -2.79% ✗ $60.4K
Feb 6, 2025 Feb 10, 2025 Baynes Roy D. Director Sell 15.0 -10,000 -24.39% ✓ $220K
Jan 31, 2025 Feb 4, 2025 ROTE WILLIAM E. President Sell 95.0 +12,549 15.09% ✓ $177.1K
Jan 31, 2025 Feb 4, 2025 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Sell 95.0 +12,549 16.31% ✓ $177.1K
Jan 31, 2025 Feb 4, 2025 Dube Eric M CEO Sell 100.0 +79,309 22.58% ✓ $1M
Jan 31, 2025 Feb 4, 2025 Inrig Jula CHIEF MEDICAL OFFICER Sell 95.0 +24,727 41.60% ✓ $106.1K
Jan 31, 2025 Feb 4, 2025 Heerma Peter CHIEF COMMERCIAL OFFICER Sell 95.0 +16,334 15.36% ✗ $103.9K
Jan 31, 2025 Feb 4, 2025 Cline Christopher R. CFO Sell 95.0 +16,308 22.12% ✗ $104.5K
Jan 31, 2025 Feb 4, 2025 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sell 95.0 +9,652 17.87% ✗ $67.4K
Jan 22, 2025 Jan 23, 2025 ROTE WILLIAM E. President Sell 45.0 -2,437 -2.85% ✓ $47.4K
Jan 22, 2025 Jan 23, 2025 Dube Eric M CEO Sell 41.3 -10,736 -2.97% ✓ $208.9K
Jan 22, 2025 Jan 23, 2025 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Sell 41.3 -2,437 -3.07% ✓ $47.4K
Jan 23, 2025 Jan 23, 2025 Baynes Roy D. Director Sell 7.5 -16,000 -34.04% ✓ $320K
Jan 22, 2025 Jan 23, 2025 Heerma Peter CHIEF COMMERCIAL OFFICER Sell 46.3 -1,584 -1.47% ✗ $30K
Jan 22, 2025 Jan 23, 2025 Cline Christopher R. CFO Sell 46.3 -865 -1.16% ✗ $16.4K
Jan 22, 2025 Jan 23, 2025 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sell 46.3 -925 -1.68% ✗ $17.5K
Jan 3, 2025 Jan 6, 2025 Inrig Jula CHIEF MEDICAL OFFICER Sell 41.3 -2,506 -4.05% ✓ $47.7K
Dec 26, 2024 Dec 27, 2024 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sell 12.5 -15,000 -21.45% ✓ $258.3K
Nov 25, 2024 Nov 25, 2024 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sell 42.5 -12,090 -18.04% ✗ $221.3K
Oct 4, 2024 Oct 4, 2024 LYONS GARY A Director Sell 7.5 -40,000 -43.96% ✓ $589.1K
Sep 30, 2024 Sep 30, 2024 Meckler Jeffrey A Director Sell 7.5 -40,000 -33.06% ✓ $562.3K
Sep 10, 2024 Sep 10, 2024 Inrig Jula CHIEF MEDICAL OFFICER Sell 50.0 -684 -1.09% ✓ $8.9K
Sep 5, 2024 Sep 9, 2024 ROTE WILLIAM E. President Sell 87.5 +2,363 2.88% ✓ $50.5K
Sep 5, 2024 Sep 9, 2024 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Sell 87.5 +2,363 3.10% ✓ $50.5K
Sep 5, 2024 Sep 9, 2024 Dube Eric M CEO Sell 87.5 +11,375 3.24% ✓ $243.4K
Sep 5, 2024 Sep 9, 2024 Inrig Jula CHIEF MEDICAL OFFICER Sell 86.3 +4,559 7.85% ✗ $25.2K
Sep 5, 2024 Sep 9, 2024 Heerma Peter CHIEF COMMERCIAL OFFICER Sell 83.8 +4,559 4.41% ✗ $25.2K
Sep 5, 2024 Sep 9, 2024 Cline Christopher R. CFO Sell 86.3 +4,260 6.06% ✗ $28.7K
Sep 4, 2024 Sep 5, 2024 Cline Christopher R. CFO Sell 50.0 -514 -0.73% ✗ $4.9K
May 8, 2024 May 10, 2024 Squarer Ron Director Neutral 90.0 +6,500 29.05% ✗ -
May 8, 2024 May 10, 2024 Orwin John A Director Neutral 90.0 +6,500 29.05% ✗ -
May 8, 2024 May 10, 2024 Williams Brinkley Ruth Director Neutral 90.0 +6,500 50.98% ✗ -
May 8, 2024 May 10, 2024 Poole Sandra Director Neutral 90.0 +6,500 38.24% ✗ -
May 8, 2024 May 10, 2024 Meckler Jeffrey A Director Neutral 85.0 +6,500 8.72% ✗ -
May 8, 2024 May 10, 2024 LYONS GARY A Director Neutral 90.0 +6,500 14.61% ✗ -
May 8, 2024 May 10, 2024 COUGHLIN TIMOTHY Director Neutral 90.0 +6,500 15.29% ✗ -
May 8, 2024 May 10, 2024 Bruhn Suzanne Louise Director Neutral 90.0 +6,500 41.27% ✗ -
May 8, 2024 May 10, 2024 Baynes Roy D. Director Neutral 90.0 +6,500 26.53% ✗ -
Apr 11, 2024 Apr 12, 2024 Cline Christopher R. CFO Sell 52.5 -54 -0.08% ✗ $364
Jan 31, 2024 Feb 2, 2024 Dube Eric M CEO Sell 95.0 +115,878 49.37% ✓ $166.4K
Jan 31, 2024 Feb 2, 2024 ROTE WILLIAM E. President Sell 91.3 +20,236 33.46% ✓ $41.5K
Jan 31, 2024 Feb 2, 2024 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sell 91.3 +10,680 25.84% ✗ $24.1K
Jan 31, 2024 Feb 2, 2024 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Sell 91.3 +20,236 36.11% ✓ $41.5K
Jan 31, 2024 Feb 2, 2024 Heerma Peter CHIEF COMMERCIAL OFFICER Sell 91.3 +20,805 26.44% ✗ $35.8K
Jan 31, 2024 Feb 2, 2024 Inrig Jula CHIEF MEDICAL OFFICER Sell 91.3 +22,826 64.76% ✗ $18.5K
Jan 31, 2024 Feb 2, 2024 Cline Christopher R. CFO Sell 91.3 +21,182 42.60% ✗ $32.6K
Jan 23, 2024 Jan 25, 2024 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Sell 41.3 -2,062 -3.55% ✓ $18.5K
Jan 23, 2024 Jan 25, 2024 Dube Eric M CEO Sell 37.5 -7,873 -3.25% ✓ $70.5K
Jan 23, 2024 Jan 25, 2024 Cline Christopher R. CFO Sell 47.5 -853 -1.69% ✗ $7.7K